Literature DB >> 22213010

Chemical transfection of dye-conjugated microRNA precursors for microRNA functional analysis of M2 macrophages.

Yee Seng Ng1, Hernan Roca, David Fuller, Sudha Sud, Kenneth J Pienta.   

Abstract

MicroRNAs (miRNAs) are short noncoding ribonucleic acids known to affect gene expression at the translational level and there is mounting evidence that miRNAs play a role in the function of tumor-associated macrophages (TAMs). To aid the functional analyses of miRNAs in an in-vitro model of TAMs known as M2 macrophages, a transfection method to introduce artificial miRNA constructs or miRNA molecules into primary human monocytes is needed. Unlike differentiated macrophages or dendritic cells, undifferentiated primary human monocytes have been known to show resistance to lentiviral transduction. To circumvent this challenge, other techniques such as electroporation and chemical transfection have been used in other applications to deliver small gene constructs into human monocytes. To date, no studies have compared these two methods objectively to evaluate their suitability in the miRNA functional analysis of M2 macrophages. Of the methods tested, the electroporation of miRNA-construct containing plasmids and the chemical transfection of miRNA precursor molecules are the most efficient approaches. The use of a silencer siRNA labeling kit (Ambion) to conjugate Cy 3 fluorescence dyes to the precursor molecules allowed the isolation of successfully transfected cells with fluorescence-activated cell sorting. The chemical transfection of these dye-conjugated miRNA precursors yield an efficiency of 37.5 ± 0.6% and a cell viability of 74 ± 1%. RNA purified from the isolated cells demonstrated good quality, and was fit for subsequent mRNA expression qPCR analysis. While electroporation of plasmids containing miRNA constructs yield transfection efficiencies comparable to chemical transfection of miRNA precursors, these electroporated primary monocytes seemed to have lost their potential for differentiation. Among the most common methods of transfection, the chemical transfection of dye-conjugated miRNA precursors was determined to be the best-suited approach for the functional analysis of M2 macrophages.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22213010      PMCID: PMC3681413          DOI: 10.1002/jcb.24041

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  26 in total

1.  Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes.

Authors:  S Neil; F Martin; Y Ikeda; M Collins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Nucleoporation of dendritic cells: efficient gene transfer by electroporation into human monocyte-derived dendritic cells.

Authors:  Petra Lenz; Silvia M Bacot; Michelle R Frazier-Jessen; Gerald M Feldman
Journal:  FEBS Lett       Date:  2003-03-13       Impact factor: 4.124

3.  Stable transduction of primary human monocytes by simian lentiviral vector PBj.

Authors:  Michael D Mühlebach; Nina Wolfrum; Silke Schüle; Ulrich Tschulena; Ralf Sanzenbacher; Egbert Flory; Klaus Cichutek; Matthias Schweizer
Journal:  Mol Ther       Date:  2005-09-16       Impact factor: 11.454

4.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 5.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

Authors:  Alberto Mantovani; Silvano Sozzani; Massimo Locati; Paola Allavena; Antonio Sica
Journal:  Trends Immunol       Date:  2002-11       Impact factor: 16.687

6.  Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.

Authors:  Rui Wang; Jie Zhang; Sufeng Chen; Meng Lu; Xiaoyang Luo; Shihua Yao; Shilei Liu; Ying Qin; Haiquan Chen
Journal:  Lung Cancer       Date:  2011-05-20       Impact factor: 5.705

7.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

8.  Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Authors:  Frank A W Verreck; Tjitske de Boer; Dennis M L Langenberg; Marieke A Hoeve; Matthijs Kramer; Elena Vaisberg; Robert Kastelein; Arend Kolk; René de Waal-Malefyt; Tom H M Ottenhoff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205

9.  Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes.

Authors:  Karine Triques; Mario Stevenson
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Small interfering RNA (siRNA) delivery into monocyte-derived dendritic cells by electroporation.

Authors:  Alexander T Prechtel; Nadine M Turza; Alexandros A Theodoridis; Mirko Kummer; Alexander Steinkasserer
Journal:  J Immunol Methods       Date:  2006-03-06       Impact factor: 2.303

View more
  2 in total

1.  Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer.

Authors:  Hernan Roca; James Hernandez; Savannah Weidner; Richard C McEachin; David Fuller; Sudha Sud; Taibriana Schumann; John E Wilkinson; Alexander Zaslavsky; Hangwen Li; Christopher A Maher; Stephanie Daignault-Newton; Patrick N Healy; Kenneth J Pienta
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

2.  miRNA profiles of monocyte-lineage cells are consistent with complicated roles in HIV-1 restriction.

Authors:  Jeanne M Sisk; Janice E Clements; Kenneth W Witwer
Journal:  Viruses       Date:  2012-09-25       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.